Traws Pharma, Inc. Class of Warrant or Right, Outstanding
Traws Pharma, Inc. (TRAW) had Class of Warrant or Right, Outstanding of 35.51 million shares as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes
us-gaap:ClassOfWarrantOrRightOutstanding · last filed 2026-08-14
- 2026-06-30: Class of Warrant or Right, Outstanding 35.51M shares.
- 2026-03-31: Class of Warrant or Right, Outstanding 4.60M shares.
- 2025-12-31: Class of Warrant or Right, Outstanding 4.60M shares.
- 2025-09-30: Class of Warrant or Right, Outstanding 5.65M shares.
| Period end | Class of Warrant or Right, Outstanding | Class of Warrant or Right, Outstanding as first filed |
|---|---|---|
| 2026-06-30 | 35.51M shares 10-Q · filed 2026-08-14 | |
| 2026-03-31 | 4.60M shares 10-Q · filed 2026-05-15 | |
| 2025-12-31 | 4.60M shares 10-Q · filed 2026-08-14 | |
| 2025-09-30 | 5.65M shares 10-Q · filed 2025-11-13 | |
| 2025-06-30 | 5.65M shares 10-Q · filed 2025-08-14 | |
| 2025-03-31 | 5.85M shares 10-Q · filed 2025-05-15 | |
| 2024-12-31 | 7.23M shares 10-K · filed 2026-04-15 | |
| 2024-09-30 | 12.65K shares 10-Q · filed 2024-11-14 | |
| 2024-06-30 | 316.21K shares 10-Q · filed 2024-08-15 | |
| 2024-03-31 | 316.21K shares 10-Q · filed 2024-05-15 | |
| 2023-12-31 | 12.65K shares 10-K · filed 2025-03-31 | 316.21K shares 10-K · filed 2024-04-01 |
| 2023-09-30 | 346.18K shares 10-Q · filed 2023-11-14 | |
| 2023-06-30 | 353.51K shares 10-Q · filed 2023-08-14 | |
| 2023-03-31 | 353.51K shares 10-Q · filed 2023-05-15 | |
| 2022-12-31 | 353.51K shares 10-K · filed 2024-04-01 | |
| 2022-09-30 | 500.11K shares 10-Q · filed 2022-11-14 | |
| 2022-06-30 | 500.11K shares 10-Q · filed 2022-08-15 | |
| 2022-03-31 | 500.11K shares 10-Q · filed 2022-05-13 | |
| 2021-12-31 | 500.11K shares 10-K · filed 2023-03-30 | |
| 2021-09-30 | 505.11K shares 10-Q · filed 2021-11-15 | |
| 2021-06-30 | 519.73K shares 10-Q · filed 2021-08-16 | |
| 2021-03-31 | 7.81M shares 10-Q · filed 2021-05-17 | |
| 2020-12-31 | 681.61K shares 10-K · filed 2022-03-21 | 10.22M shares 10-K · filed 2021-03-18 |
| 2020-09-30 | 11.62M shares 10-Q · filed 2020-11-16 | |
| 2020-06-30 | 21.99M shares 10-Q · filed 2020-08-12 | |
| 2020-03-31 | 28.75M shares 10-Q · filed 2020-05-15 | |
| 2019-12-31 | 55.95M shares 10-K · filed 2021-03-18 | 55.99M shares 10-K · filed 2020-03-27 |
| 2019-09-30 | 5.61M shares 10-Q · filed 2019-11-12 | |
| 2019-06-30 | 5.50M shares 10-Q · filed 2019-08-14 | |
| 2019-03-31 | 5.50M shares 10-Q · filed 2019-05-15 | |
| 2018-12-31 | 5.73M shares 10-K · filed 2020-03-27 | |
| 2018-09-30 | 5.73M shares 10-Q · filed 2018-11-14 | |
| 2018-06-30 | 85.88M shares 10-Q · filed 2018-08-14 | |
| 2018-03-31 | 15.23M shares 10-Q · filed 2018-05-15 | |
| 2017-12-31 | 219.65K shares 10-K · filed 2019-04-01 | 3.29M shares 10-K · filed 2018-03-16 |
| 2017-09-30 | 3.29M shares 10-Q · filed 2017-11-09 | |
| 2017-06-30 | 3.29M shares 10-Q · filed 2017-08-14 | |
| 2017-03-31 | 3.53M shares 10-Q · filed 2017-05-15 | |
| 2016-12-31 | 3.53M shares 10-K · filed 2018-03-16 | |
| 2016-09-30 | 3.53M shares 10-Q · filed 2016-11-14 | |
| 2015-12-31 | 460.00 shares 10-K · filed 2017-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |